跳至主要内容
临床试验/JPRN-UMIN000010449
JPRN-UMIN000010449已完成未知

Study of the clinical efficacy and number of days of administration of cefditoren pivoxil in the treatment of adult acute uncomplicated cystitis - Clinical efficacy of cefditoren pivoxil for adult cystitis

Okayama Urological Research Group0 个研究点目标入组 120 人开始时间: 2013年4月10日最近更新:
适应症
相关药物

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Co-presence of another urinary tract infection in addition to acute uncomplicated cystitis. 2) Symptoms of urinary tract infection within 4 weeks prior to onset of the present infection. 3) Existence of systemic (diabetes mellitus, ongoing administration of an immunosuppressive agent, ongoing long-term administration of steroid, etc.) or local factors that might induce and/or promote a urinary tract infection. 4) Symptoms/findings have improved as a result of administration of another antimicrobial agent. 5) History of allergy, possibly due to cephem antibiotics. 6) A physical constitution that predisposes to development of bronchial asthma, rash, urticaria or other allergic symptoms. 7) Moderate or more severe renal dysfunction. 8) Women who are or may be pregnant, are breast-feeding, or desire to become pregnant during the study drug administration period. 9) Any other reason that the chief investigator judges as rendering a patient inappropriate for enrollment.

研究者

发起方
Okayama Urological Research Group

相似试验

已完成
不适用
Study of the clinical efficacy and number of days of tebipenem pivoxil administration for the treatment of pediatric bacterial pneumonia.Pediatric bacterial pneumonia
JPRN-UMIN000010144Department of Pediatrics, Kawasaki Medical School100
撤回
不适用
A Study to Evaluate the Use of GALA (Trademark), a Preservation Solution for Blood Vessels in Patients Undergoing Coronary Artery Bypass Graft Surgery.
ACTRN12613000707763Mobius Medical Pty Ltd25
进行中(未招募)
不适用
Clinical Study to Investigate the Long-Term Efficacy, Safety, and Immunogenicity of human-cl rhFVIII in Previously Treated Patients with Severe Haemophilia A – Extension Study to GENA-01Severe haemophilia A (FVIII:C <1%)MedDRA version: 12.1Level: LLTClassification code 10018937Term: Haemophilia A
EUCTR2010-023242-69-DEOctapharma AG25
尚未招募
Unknown
A study to assess the clinical effectiveness and safety of intravesical mitomycin-C and gemcitabine sequential therapy in patients with high risk non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) Therapy: Prospective, multicenter, open-label trial
KCT0009491ational Cancer Center82
进行中(未招募)
1 期
A Clinical Study to Assess the Efficacy and Onset of Pain Relief of Topical MFC51123 Diclofenac-Menthol Gel versus Controls in Ankle SpraiPain and inflammation due to Grade I or Grade II acute sprain of the lateral ankleMedDRA version: 17.0Level: PTClassification code 10061218Term: InflammationSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 17.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 17.0Level: PTClassification code 10024453Term: Ligament sprainSystem Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2013-000992-33-DEGlaxoSmithKline Consumer Healthcare